Abiopharma

🔍 Debora Horvath D (Director)

Company: REDWOOD TRUST INC (RWT)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 25,065 shares of Common stock at $5.56 per share (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 128,307.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: IRA | shares_owned_after: 9,568.49
• Sold 25,065 shares of Deferred Stock Units at $6.56 per share (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F1, F4, F5

Footnotes:

• F1: This transaction relates to the distribution and/or conversion of Deferred Stock Units to common stock in accordance with the deferral election made with respect to director compensation and dividend equivalent rights according to the terms and conditions of the Redwood Trust Inc. Amended and Restated Executive Deferred Compensation Plan.
• F2: Represents the value of the distribution and/or conversion of Deferred Stock Units to common stock under the Executive Deferred Compensation Plan, based on the fair market value of Redwood Trust, Inc. common stock on the transaction date.
• F3: Represents average grant date fair value of Deferred Stock Units acquired based on the fair market value of Redwood Trust, Inc. common stock on the acquisition dates.
• F4: Deferred Stock Units were subject to a mandatory holding period and are being delivered to the Participant at the time provided in the Deferral Election Form, according to the terms and conditions of the Redwood Trust, Inc. Amended and Restated Executive Deferred Compensation Plan.
• F5: No expiration date is applicable to Deferred Stock Units.